Prevention Strategies. In addition to the above responsibilities, the Designated Liaisons from the School, the Police Department and the Middlesex District Attorney’s Office will meet regularly for the following purposes: (1) to discuss incidents of violence or bullying (as defined under X.X. x. 71, § 37O) in school or outside of school that affects students of the school; (2) to discuss any use, abuse or distribution of alcohol and/or other controlled substances or any other criminal activity affecting students; (3) to identify strategies to reduce such activities and to promote a safe and nurturing school environment; (4) to discuss community resources available for students at risk of harm from violence, abuse or neglect; (5) to develop violence prevention and intervention programs, identification, protocol and curricula as required by X.X. x. 12 § 32; and (6) to outline the necessary action plan for implementation of such strategies.

Prevention Strategies. The District will follow local, state, and federal health and safety guidelines to ensure employees’ safety. The District will provide the layered preventive measures outlined in this MOU. The following measures are guided by current OSPI guidelines, which include Washington State Department of Health (“DOH”) and Washington State Department of Labor & Industries requirements (“L&I”), along with Public Health – Seattle & King County (“PHSKC”) recommendations. The District and SEA agree these guidelines may change and need to be revisited periodically. Regardless of the level of community transmission, all schools will use and layer prevention strategies with fidelity. The following prevention strategies are essential to safe delivery of in-person instruction and help to mitigate COVID transmission in schools: Universal and correct use of masks Physical distancing to the extent possible Improving when needed, monitoring, and sustaining ventilation and air quality Handwashing and respiratory etiquette Cleaning and disinfecting Staying home when sick Contact tracing in combination with isolation and quarantine and in collaboration with Public Health – Seattle & King County Responding to symptoms/cases of COVID

Prevention Strategies. The district will implement a range of prevention strategies including individual, classroom, school, and district-level approaches. Whenever possible, the district will implement evidence-based prevention programs that are designed to increase social competency, improve school climate, and eliminate harassment, intimidation and bullying in schools.

Prevention Strategies. MDNR will conduct or assist with the following: 1. Targeted deer management efforts (e.g., baiting ban; Xxxxxxx et al. 2006, Xxxxxx et al. 2016) in DMUs 452 and 487 on a local scale to prevent transmission of bTB between deer and cattle. 2. Provide APHIS WS with approval to conduct targeted removal of deer on cattle farms within identified bTB concentration areas in DMUs 452 and 487. 3. Maintain a simple process for cattle producers and adjacent landowners to obtain no-cost disease control permits valid for harvesting deer year-round in DMUs 452 and 487. 4. Work with collaborators to continue conducting research concerning the epidemiology of bTB and potential intervention strategies, including targeted removal, vaccination (Xxxxxxxx et al. 2012, Xxxxxx et al. 2016, XxxXxxxxxxx et al. 2018), and non-lethal methods (e.g., livestock protection dogs; Xxxxxxx et al. 2010). Incorporate relevant research findings into existing surveillance and disease reduction activities as resources allow.

Prevention Strategies. The District will follow local, state, and federal health and safety guidelines to ensure employees’ safety. The District will provide the layered preventive measures outlined in this MOU. The following measures are guided by current OSPI guidelines, which include Washington State Department of Health (“DOH”) and Washington State Department of Labor & Industries requirements (“L&I”), along with Public Health – Seattle & King County (“PHSKC”) recommendations. The District and SEA agree these guidelines may change and need to be revisited periodically. Regardless of the level of community transmission, all schools will use and layer prevention strategies with fidelity. The following prevention strategies are essential to safe delivery of in-person instruction and help to mitigate COVID transmission in schools:  Universal and correct use of masks  Physical distancing to the extent possible  Improving when needed, monitoring, and sustaining ventilation and air quality  Handwashing and respiratory etiquette  Cleaning and disinfecting  Staying home when sick  Contact tracing in combination with isolation and quarantine and in collaboration with Public Health – Seattle & King County  Responding to symptoms/cases of COVID

Prevention Strategies. 5.2.1 Cenpatico contracts for Prevention Services based upon identified community needs. Contracted strategies include:  Community Based Projects  Problem Identification and Referral  Social Marketing  Community Education and Training  Life Skills  Peer Leadership  Personal and Cultural Development  Family Support  Education

Related to Prevention Strategies

Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.
Curriculum Development This includes the analysis and coordination of textual materials; constant review of current literature in the field, some of which are selected for the college library collection, the preparation of selective, descriptive materials such as outlines and syllabi; conferring with other faculty and administration on curricular problems; and, the attendance and participation in inter and intra-college conferences and advisory committees.
Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)
Product Development (a) Supplier may develop enhancements it intends to incorporate into the BioGlue Surgical Adhesive during the term of this Agreement that have potential application to the Company Product (“Enhancements”). Unless otherwise agreed by the parties, at least once every six months during the Term, representatives of each of BioForm and Supplier shall hold a meeting in accordance with Sections 4.4 and 8.4 (the “Product Development Meeting”) at which Supplier will present Enhancements for BioForm to consider for application to the Company Product. At such Product Development Meeting, BioForm will also present its marketing plans (pursuant to Section 4.4) for the period and any information or feedback that BioForm reasonably believes may lead to Improvements. Within 30 calendar days following each Product Development Meeting, Supplier shall deliver a notice to BioForm (the “Enhancements Notice”) that shall describe the Enhancements that were presented by Supplier at such Product Development Meeting. Within 30 calendar days following receipt of the Enhancements Notice, BioForm may notify Supplier in writing if BioForm elects that any Enhancement described in the Enhancements Notice shall become an Improvement. If BioForm does provide such notice to Supplier during such 30-calendar day period, then BioForm and Supplier shall agree on a timeline for implementation of the Improvement in new Product Specifications for Company Product. If BioForm does not provide such a notice, said Enhancement shall not be implemented into the Company Product. The Enhancements Notice may also describe any potential Enhancements presented by Supplier at the Product Development Meeting, but BioForm shall not be required to take any action under this Section 8.4 with respect to such potential Enhancements until such time as they are presented by Supplier as Enhancements at a future Product Development Meeting. All Enhancements and potential Enhancement information provided by Supplier shall be considered Supplier Confidential Information. (b) From time to time, each party may request the other party to participate in joint projects to develop Improvements. Neither party is obligated to participate in such projects, and in each **** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. instance, each party’s decision whether to participate will be made in such party’s sole discretion. If both parties mutually agree to participate in such a project (a “Program”), the parties will promptly prepare a mutually agreeable written development agreement specifying the development activities to be performed by and the research and development tasks assigned to each party (the “Development Agreement”). All allocation of Intellectual Property rights with respect to any Program will be set forth in writing in the Development Agreement. (c) In the absence of a Development Agreement, (i) BioForm and Supplier shall retain joint ownership of Intellectual Property rights in which there is joint inventorship by BioForm (or its Affiliates) and Supplier, as determined in accordance with United States patent law, with Supplier’s rights in such joint ownership being subject to the license rights of BioForm under this Agreement, (ii) any Intellectual Property rights related to the Company Products, Enhancements, and Improvements that are created solely by employees or consultants of Supplier during the Term shall be considered to be Intellectual Property rights of Supplier, subject to the license rights of BioForm under this Agreement, and (iii) any Intellectual Property rights related to the Company Products and Improvements that are created solely by employees or consultants of BioForm or any of its Affiliates during the Term shall be considered to be Intellectual Property rights of BioForm. BioForm hereby grants to Supplier a perpetual, royalty free, world-wide, nonexclusive license to Supplier under such Blocking Intellectual Property to make, use, and sell such Intellectual Property outside the Field. “Blocking Intellectual Property” for the purposes of Section 8.4(c)(iii) shall mean Intellectual Property necessary for Supplier to make, use, or sell SA Product.
Strategies The ESC will seek to achieve employment stability strategies as follows: - current and multi-year strategies should be developed within the resources available. Such strategies could include, but not necessarily be limited to, planning, retraining, identifying ways of determining employees= skills, training and experience previously achieved, early retirement, voluntary exit programs, alternative assignment, secondment, employee career counselling, job sharing, job trading, job shadowing, and professional development; - discussions between the parties which explore these possible strategies would assist in the development of appropriate enhancements to Employment Stability; - data which is relevant to employment stability shall be made available to both parties.
Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.
Development Within twenty (20) Working Days after the Commencement Date and in accordance with paragraphs 3.10 to 3.12 (Amendment and Revision), the Contractor will prepare and deliver to the Authority for approval the full and final Security Plan which will be based on the draft Security Plan set out in Appendix B.
Project Development a. Collaborate with COUNTY and project clients to identify requirements and develop a project Scope Statement. a. Develop a Work Breakdown Structure (WBS) for each project. b. Evaluate Scope Statement to develop a preliminary cost estimate and determinate whether project be vendor bid or be executed under a Job Order Contract (JOC).
Protocols Each party hereby agrees that the inclusion of additional protocols may be required to make this Agreement specific. All such protocols shall be negotiated, determined and agreed upon by both parties hereto.
Strategy As an organization without operational services (fuel, maintenance, etc.), and in consideration that the majority of potential issues come from boat maintenance whereby the boats are personal property, the predominant strategy will be the minimization of on-site waste. With this approach, the organization will have minimal potential impact on the environment and reduce regulatory risk. To accomplish this, requirements will be established by policy, periodic communications shall occur, and audits will be utilized to provide feedback for improvement.

Prevention Strategies Sample Clauses

Filter & Search

Related Clauses

Parent Clauses

Sub-Clauses

Related to Prevention Strategies